http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102697733-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2008-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102697733-B |
| titleOfInvention | A kind of interior parcel immunotoxin connects the Poly(D,L-lactide-co-glycolide nano-particle of antibody outward |
| abstract | The invention belongs to biomedicine field, more specifically, the invention discloses Poly(D,L-lactide-co-glycolide (PLGA) nano-particle, Preparation Method And The Use that a kind of interior packaged toxin connects antibody outward.The Poly(D,L-lactide-co-glycolide of interior parcel PE38KDEL I type sudden change Ligation in vitro humanization SM5-1 antibody disclosed by the invention has that anti-tumor activity is high, non-specific toxicities and immunogenicity is little, the sensitivity of antagonism PE neutrality antibody is low advantage, can be used for preparing antitumor drug. |
| priorityDate | 2007-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.